These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27373781)

  • 21. The pattern of urinary acylcarnitines determined by electrospray mass spectrometry: a new tool in the diagnosis of diabetes mellitus.
    Möder M; Kiessling A; Löster H; Brüggemann L
    Anal Bioanal Chem; 2003 Jan; 375(2):200-10. PubMed ID: 12560963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bile Acid Metabolome after an Oral Lipid Tolerance Test by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
    Schmid A; Neumann H; Karrasch T; Liebisch G; Schäffler A
    PLoS One; 2016; 11(2):e0148869. PubMed ID: 26863103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Association Between Acylcarnitine Metabolites and Cardiovascular Disease in Chinese Patients With Type 2 Diabetes Mellitus.
    Zhao S; Feng XF; Huang T; Luo HH; Chen JX; Zeng J; Gu M; Li J; Sun XY; Sun D; Yang X; Fang ZZ; Cao YF
    Front Endocrinol (Lausanne); 2020; 11():212. PubMed ID: 32431666
    [No Abstract]   [Full Text] [Related]  

  • 24. Association of the CD36 gene with impaired glucose tolerance, impaired fasting glucose, type-2 diabetes, and lipid metabolism in essential hypertensive patients.
    Wang Y; Zhou XO; Zhang Y; Gao PJ; Zhu DL
    Genet Mol Res; 2012 Aug; 11(3):2163-70. PubMed ID: 22869067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early Prediction of Developing Type 2 Diabetes by Plasma Acylcarnitines: A Population-Based Study.
    Sun L; Liang L; Gao X; Zhang H; Yao P; Hu Y; Ma Y; Wang F; Jin Q; Li H; Li R; Liu Y; Hu FB; Zeng R; Lin X; Wu J
    Diabetes Care; 2016 Sep; 39(9):1563-70. PubMed ID: 27388475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers for predicting type 2 diabetes development-Can metabolomics improve on existing biomarkers?
    Savolainen O; Fagerberg B; Vendelbo Lind M; Sandberg AS; Ross AB; Bergström G
    PLoS One; 2017; 12(7):e0177738. PubMed ID: 28692646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Untargeted metabolomic profiling reveals molecular signatures associated with type 2 diabetes in Nigerians.
    Doumatey AP; Shriner D; Zhou J; Lei L; Chen G; Oluwasola-Taiwo O; Nkem S; Ogundeji A; Adebamowo SN; Bentley AR; Gouveia MH; Meeks KAC; Adebamowo CA; Adeyemo AA; Rotimi CN
    Genome Med; 2024 Mar; 16(1):38. PubMed ID: 38444015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visceral adipose tissue accumulation and cardiovascular disease risk profile in postmenopausal women with impaired glucose tolerance or type 2 diabetes.
    Lemieux S; Bédard A; Piché MÈ; Weisnagel SJ; Corneau L; Bergeron J
    Clin Endocrinol (Oxf); 2011 Mar; 74(3):340-5. PubMed ID: 21092050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum progranulin concentrations are not responsive during oral lipid tolerance test and oral glucose tolerance test.
    Schmid A; Leszczak S; Ober I; Schäffler A; Karrasch T
    Horm Metab Res; 2015 Jul; 47(8):571-6. PubMed ID: 25565096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired glucose tolerance is not associated with lipid intolerance.
    Henkel E; Temelkova-Kurktschiev T; Koehler C; Pietzsch J; Leonhardt W; Hanefeld M
    Diabetes Nutr Metab; 2002 Apr; 15(2):84-90. PubMed ID: 12059096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome.
    Saaristo T; Peltonen M; Lindström J; Saarikoski L; Sundvall J; Eriksson JG; Tuomilehto J
    Diab Vasc Dis Res; 2005 May; 2(2):67-72. PubMed ID: 16305061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Several Metabolite Families Display Inflexibility during Glucose Challenge in Patients with Type 2 Diabetes: An Untargeted Metabolomics Study.
    Fanni G; Eriksson JW; Pereira MJ
    Metabolites; 2023 Jan; 13(1):. PubMed ID: 36677056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accumulation of unsaturated acylcarnitine molecular species during acute myocardial ischemia: metabolic compartmentalization of products of fatty acyl chain elongation in the acylcarnitine pool.
    Ford DA; Han X; Horner CC; Gross RW
    Biochemistry; 1996 Jun; 35(24):7903-9. PubMed ID: 8672492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.
    Amoah AG; Owusu SK; Schuster DP; Osei K
    S Afr Med J; 2002 May; 92(5):377-84. PubMed ID: 12108171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma acylcarnitine levels increase with healthy aging.
    Jarrell ZR; Smith MR; Hu X; Orr M; Liu KH; Quyyumi AA; Jones DP; Go YM
    Aging (Albany NY); 2020 Jun; 12(13):13555-13570. PubMed ID: 32554854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated biomarker profiling of the metabolome associated with impaired fasting glucose and type 2 diabetes mellitus in large-scale Chinese patients.
    Long J; Yang H; Yang Z; Jia Q; Liu L; Kong L; Cui H; Ding S; Qin Q; Zhang N; Feng X; Yan S; Tang J; Chen S; Han Y; Jiang T; Wen Z; Qi N; Deng K; Sun Z; Lin H; Yan D
    Clin Transl Med; 2021 Jun; 11(6):e432. PubMed ID: 34185410
    [No Abstract]   [Full Text] [Related]  

  • 38. Obesity and metabolic abnormalities in offspring of subjects with diabetes mellitus.
    Praveen EP; Kulshreshtha B; Khurana ML; Sahoo JP; Gupta N; Kumar G; Dwivedi SN; Ammini AC
    Diabetes Technol Ther; 2010 Sep; 12(9):723-30. PubMed ID: 20707738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultra-high performance liquid chromatography tandem mass spectrometry for comprehensive analysis of urinary acylcarnitines.
    Zuniga A; Li L
    Anal Chim Acta; 2011 Mar; 689(1):77-84. PubMed ID: 21338760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.